DK192387A - Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler - Google Patents

Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler

Info

Publication number
DK192387A
DK192387A DK192387A DK192387A DK192387A DK 192387 A DK192387 A DK 192387A DK 192387 A DK192387 A DK 192387A DK 192387 A DK192387 A DK 192387A DK 192387 A DK192387 A DK 192387A
Authority
DK
Denmark
Prior art keywords
tnf
preparation
medicinal products
tumor cross
cross factor
Prior art date
Application number
DK192387A
Other languages
English (en)
Other versions
DK192387D0 (da
Inventor
Renate Urbaschek
Bernhard Urbaschek
Daniela MAENNEL
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of DK192387D0 publication Critical patent/DK192387D0/da
Publication of DK192387A publication Critical patent/DK192387A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK192387A 1986-04-18 1987-04-14 Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler DK192387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863613167 DE3613167A1 (de) 1986-04-18 1986-04-18 Verwendung von tnf zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
DK192387D0 DK192387D0 (da) 1987-04-14
DK192387A true DK192387A (da) 1987-10-19

Family

ID=6299019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK192387A DK192387A (da) 1986-04-18 1987-04-14 Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler

Country Status (5)

Country Link
US (1) US4861587A (da)
EP (1) EP0241889A3 (da)
JP (1) JPS62249928A (da)
DE (1) DE3613167A1 (da)
DK (1) DK192387A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613166A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5741667A (en) * 1994-05-27 1998-04-21 Genentech, Inc. Tumor necrosis factor receptor-associated factors
US5708142A (en) * 1994-05-27 1998-01-13 Genentech, Inc. Tumor necrosis factor receptor-associated factors
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
ZA966663B (en) 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US20040249130A1 (en) * 2002-06-18 2004-12-09 Martin Stanton Aptamer-toxin molecules and methods for using same
US20040022727A1 (en) * 2002-06-18 2004-02-05 Martin Stanton Aptamer-toxin molecules and methods for using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS62169731A (ja) * 1986-01-21 1987-07-25 Green Cross Corp:The 細胞分化誘導剤
DE3613166A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln

Also Published As

Publication number Publication date
JPS62249928A (ja) 1987-10-30
EP0241889A3 (de) 1989-10-18
EP0241889A2 (de) 1987-10-21
DK192387D0 (da) 1987-04-14
US4861587A (en) 1989-08-29
DE3613167A1 (de) 1987-10-29

Similar Documents

Publication Publication Date Title
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK51493A (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK215987D0 (da) Farmaceutiske praeparater af syrelabile stoffer tiloral indgift
IS2730A7 (is) Aðferð til að framleiða lyfjablöndu
DK481585A (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
DK153387D0 (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK165355C (da) Fremgangsmaade til mikroindkapsling af laegemidler
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK192387A (da) Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK560989D0 (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
DK192287D0 (da) Anvendelse af tnf (tumornekrosefaktor) til fremstilling af laegemidler
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO875359L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK100586D0 (da) Plaster til vedvarende frigoerelse af laegemidler
DK624587A (da) Farmaceutisk praeparat indeholdende imidazolderivater
DK441987D0 (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK396582A (da) Fremgangsmaade til fremstilling af farmaceutisk praeparat
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment